[Effect of inhibitors of protein and nucleic acid synthesis on the shape of the nucleoid of Escherichia coli].
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000096:biosynthesis*; D002467:Cell Nucleus / Q000648:ultrastructure; D002499:Centrifugation, Density Gradient; D002701:Chloramphenicol / Q000494:pharmacology; D004269:DNA, Bacterial / Q000096:biosynthesis*; D003609:Dactinomycin / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D004996:Ethidium / Q000494:pharmacology; D008854:Microscopy, Electron; D009268:Nalidixic Acid / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D012329:RNA, Bacterial / Q000096:biosynthesis; D012293:Rifampin / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014158:Transcription, Genetic
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D004269:DNA, Bacterial; D012329:RNA, Bacterial; D003609:Dactinomycin; D009268:Nalidixic Acid; D011691:Puromycin; D004917:Erythromycin; D002701:Chloramphenicol; D004996:Ethidium; D013752:Tetracycline; D012293:Rifampin; D013307:Streptomycin
Einfluss von Inhibitoren der Protein- und Nucleinsäuresynthese auf die Gestalt des Nucleoids von Escherichia coli